139 related articles for article (PubMed ID: 19810163)
1. [The inhibition of the Sonic Hedgehog (SHh) pathway improves the effects of chemotherapy in a model of ductal carcinoma of the pancreas in mice].
Larsen CJ
Bull Cancer; 2009 Sep; 96(9):829. PubMed ID: 19810163
[No Abstract] [Full Text] [Related]
2. Cancer. Breaching the cancer fortress.
Olson P; Hanahan D
Science; 2009 Jun; 324(5933):1400-1. PubMed ID: 19520948
[No Abstract] [Full Text] [Related]
3. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
Olive KP; Jacobetz MA; Davidson CJ; Gopinathan A; McIntyre D; Honess D; Madhu B; Goldgraben MA; Caldwell ME; Allard D; Frese KK; Denicola G; Feig C; Combs C; Winter SP; Ireland-Zecchini H; Reichelt S; Howat WJ; Chang A; Dhara M; Wang L; Rückert F; Grützmann R; Pilarsky C; Izeradjene K; Hingorani SR; Huang P; Davies SE; Plunkett W; Egorin M; Hruban RH; Whitebread N; McGovern K; Adams J; Iacobuzio-Donahue C; Griffiths J; Tuveson DA
Science; 2009 Jun; 324(5933):1457-61. PubMed ID: 19460966
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine resistance in pancreatic cancer: picking the key players.
Kim MP; Gallick GE
Clin Cancer Res; 2008 Mar; 14(5):1284-5. PubMed ID: 18316544
[No Abstract] [Full Text] [Related]
5. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
[TBL] [Abstract][Full Text] [Related]
6. Transport properties of pancreatic cancer describe gemcitabine delivery and response.
Koay EJ; Truty MJ; Cristini V; Thomas RM; Chen R; Chatterjee D; Kang Y; Bhosale PR; Tamm EP; Crane CH; Javle M; Katz MH; Gottumukkala VN; Rozner MA; Shen H; Lee JE; Wang H; Chen Y; Plunkett W; Abbruzzese JL; Wolff RA; Varadhachary GR; Ferrari M; Fleming JB
J Clin Invest; 2014 Apr; 124(4):1525-36. PubMed ID: 24614108
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer.
Hessmann E; Patzak MS; Klein L; Chen N; Kari V; Ramu I; Bapiro TE; Frese KK; Gopinathan A; Richards FM; Jodrell DI; Verbeke C; Li X; Heuchel R; Löhr JM; Johnsen SA; Gress TM; Ellenrieder V; Neesse A
Gut; 2018 Mar; 67(3):497-507. PubMed ID: 28077438
[TBL] [Abstract][Full Text] [Related]
8. Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer.
Khan MA; Srivastava SK; Zubair H; Patel GK; Arora S; Khushman M; Carter JE; Gorman GS; Singh S; Singh AP
J Biol Chem; 2020 Jun; 295(25):8413-8424. PubMed ID: 32358063
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.
Onishi H; Morifuji Y; Kai M; Suyama K; Iwasaki H; Katano M
Cancer Sci; 2012 Jul; 103(7):1272-9. PubMed ID: 22486854
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.
Feldmann G; Habbe N; Dhara S; Bisht S; Alvarez H; Fendrich V; Beaty R; Mullendore M; Karikari C; Bardeesy N; Ouellette MM; Yu W; Maitra A
Gut; 2008 Oct; 57(10):1420-30. PubMed ID: 18515410
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models.
Pham NA; Tsao MS; Cao P; Hedley DW
Pancreas; 2007 Oct; 35(3):e16-26. PubMed ID: 17895832
[TBL] [Abstract][Full Text] [Related]
12. Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of pancreatic cancer.
Yang SH; Hsu CH; Lee JC; Tien YW; Kuo SH; Cheng AL
Oncology; 2013; 85(2):86-94. PubMed ID: 23860225
[TBL] [Abstract][Full Text] [Related]
13. ASO Author Reflections: Regulation of Chemoresistance in Pancreatic Ductal Adenocarcinoma by Scavenger Receptor CD36.
Kubo M; Eguchi H
Ann Surg Oncol; 2020 Feb; 27(2):620-621. PubMed ID: 31659646
[No Abstract] [Full Text] [Related]
14. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma.
Shang M; Weng L; Xu G; Wu S; Liu B; Yin X; Mao A; Zou X; Wang Z
J Cell Physiol; 2021 Oct; 236(10):6868-6883. PubMed ID: 33629745
[TBL] [Abstract][Full Text] [Related]
15. [Modern possibilities of chemotherapy in patients with ductal pancreatic adenocarcinoma].
Kopchak VM; Kopchak KV; Romaniv IaV
Klin Khir; 2006 Feb; (2):23-5. PubMed ID: 16826811
[TBL] [Abstract][Full Text] [Related]
16. BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance.
Wang YH; Sui YN; Yan K; Wang LS; Wang F; Zhou JH
Oncol Rep; 2015 Apr; 33(4):1699-706. PubMed ID: 25647019
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer.
Hiraya D; Kagohashi K; Sakamoto N; Kondo T; Satoh H
JOP; 2010 Mar; 11(2):186-8. PubMed ID: 20208333
[No Abstract] [Full Text] [Related]
18. [New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis].
Huguet F; Fernet M; Monnier L; Touboul E; Favaudon V
Cancer Radiother; 2011 Aug; 15(5):365-75. PubMed ID: 21664851
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin inhibits sonic hedgehog signaling and stemness features of pancreatic cancer.
Yin Y; Liu L; Zhao Z; Yin L; Bauer N; Nwaeburu CC; Gladkich J; Gross W; Hackert T; Sticht C; Gretz N; Strobel O; Herr I
Cancer Lett; 2018 Jul; 426():14-24. PubMed ID: 29627496
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model.
Guimaraes AR; Rakhlin E; Weissleder R; Thayer SP
Pancreas; 2008 Nov; 37(4):440-4. PubMed ID: 18953259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
